天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>15982-84-0

15982-84-0

中文名稱 Dual Specificity Protein Phosphatase 1/6 Inhibitor
英文名稱 Dual Specificity Protein Phosphatase 1/6 Inhibitor
CAS 15982-84-0
分子式 C22H23NO
分子量 317.42
MOL 文件 15982-84-0.mol
更新日期 2024/06/12 17:31:28
15982-84-0 結(jié)構(gòu)式 15982-84-0 結(jié)構(gòu)式

基本信息

中文別名
化合物(E/Z)-BCI
2-亞芐基-3-(環(huán)己基氨基)-2,3-二氫-1H-茚-1-酮
英文別名
NSC 150117
(E/Z)-BCI (NSC150117)
(E/Z)-BCI(DUSP6 inhibitor)
Dual Specificity Protein Phosphatase 1/6 Inhibitor
1H-Inden-1-one, 3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-

物理化學(xué)性質(zhì)

沸點484.6±45.0 °C(Predicted)
密度1.15±0.1 g/cm3(Predicted)
儲存條件2-8°C(protect from light)
儲存條件Keep in dark place,Sealed in dry,2-8°C
溶解度DMSO: 63 mg/mL (198.48 mM);Ethanol: 20 mg/mL (63.01 mM)
酸度系數(shù)(pKa)7.74±0.20(Predicted)
水溶解性水:不溶

安全數(shù)據(jù)

危險性符號(GHS)GHS hazard pictograms
GHS07
警示詞警告
危險性描述H302-H315-H319-H412
海關(guān)編碼2922390090
Dual Specificity Protein Phosphatase 1/6 Inhibitor價格(試劑級)
報價日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價格
2024/11/08S0056(E/Z)-BCI15982-84-010mM (1mL in DMSO)2432.43元
2024/11/08S0056Dual Specificity Protein Phosphatase 1/6 Inhibitor
(E/Z)-BCI
15982-84-05mg2750.96元
2024/11/08S0056Dual Specificity Protein Phosphatase 1/6 Inhibitor
(E/Z)-BCI
15982-84-025mg8790.18元

常見問題列表

生物活性
(E/Z)-BCI (BCI, NSC 150117) 是一種 dual specific phosphatase 1/6 (DUSP1/DUSP6) 和 mitogen-activated protein kinase 的抑制劑,對細(xì)胞中DUSP6和DUSP1的EC50值分別為13.3 μM和8.0 μM。(E)-BCI 在H1299肺癌細(xì)胞中通過產(chǎn)生 reactive oxygen species (ROS) 和激活內(nèi)在的線粒體途徑來誘導(dǎo)凋亡。
靶點
TargetValue
ROS
()
DUSP1
(Cell-free assay)
8.0 μM(EC50)
DUSP6
(Cell-free assay)
13.3 μM(EC50)
體外研究

(E/Z)-BCI hydrochloride (2-10 μM; 72 hours) significantly decreases cell viability in a time and dose-dependent manner in gastric epithelial cell GES1, GC cell lines, and AGS cell lines.
(E/Z)-BCI hydrochloride (0.5-4 μM; 24 hours) significantly inhibits DUSP6 expression in LPS-activated macrophages.
(E/Z)-BCI hydrochloride (0.5-2 μM; 24 hours) treatment significantly inhibits the expression of IL-1β, TNF-α and IL-6 mRNA in LPS-activated macrophages.
(E/Z)-BCI hydrochloride decreases ROS production and activates the Nrf2 pathway in LPS-activated macrophages. (E/Z)-BCI hydrochloride inhibits cell proliferation, migration and invasion in a receptor-independent manner and enhances Cisplatin (CDDP) cytotoxicity (enhances CDDP-induced cell death and apoptosis) at pharmacological concentrations in the gastric cancer (GC) cells.

Cell Viability Assay

Cell Line: Gastric epithelial cell GES1, GC cell lines (HGC27, SGC7901, MKN45, BGC823, MGC803, SNU216, NUGC4), AGS cell lines
Concentration: 2 μM, 4 μM, 6 μM, 8 μM, 10 μM
Incubation Time: 72 hours
Result: Cell viability was significantly decreased in a time and dose-dependent manner.

Western Blot Analysis

Cell Line: RAW264.7 macrophage cells (by LPS-activated macrophages)
Concentration: 0.5 μM, 1 μM, 2 μM, 4 μM
Incubation Time: 24 hours
Result: DUSP6 protein was significantly downregulated in LPS-activated macrophages.

RT-PCR

Cell Line: RAW264.7 macrophage cells (by LPS-activated macrophages)
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 24 hours
Result: The expression of IL-1β, TNF-α and IL-6 mRNA was significantly inhibited in LPS-activated macrophages.
體內(nèi)研究

(E/Z)-BCI hydrochloride (35 mg/kg; intraperitoneal injection; every 7 days; for four weeks; female BALB/c nude mice) treatment enhances cisplatin efficacy in PDX models.

Animal Model: Patient-derived xenograft (PDX) models (4-5-week-old female BALB/c nude mice)
Dosage: 35 mg/kg
Administration: Intraperitoneal injection; every 7 days; for four weeks
Result: Tumor weights in the PDX models treated plus CDDP were significantly suppressed compared with tumors from PDX model mice treated with either agent alone.
"15982-84-0" 相關(guān)產(chǎn)品信息